Public market insider buying at Wesana Health Holdings (WESA)

Public market insider buying at Wesana Health Holdings (C:WESA)

Updated Monday Jun 21, 2021 02:58 AM EDT
The K2 Principal Fund L.P., a 10% Holder, acquired 68,900 Common Shares on a direct ownership basis at prices ranging from $2.598 to $2.700 between June 14th, 2021 and June 18th, 2021. This represents a $183,990 investment into the company's shares and an account share holdings change of 5.1%.

Wesana Health Holdings is in the Uranium Sub Industry Group under the Energy Sector.

Wesana Health Holdings Inc, formerly Debut Diamonds Inc. (Debut), is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injury (TBI) and related conditions. It develops evidence-based formulations and protocols for patients to overcome neurological, psychological and mental health ailments caused by trauma. Wesana Health Holdings Inc. (WESA) has below median officer and director direct ownership compared to its micro-cap peers in the market, based on our estimate using SEDI data. According to recent regulatory filings, one insider has invested a total amount of $183,990.

Headlines: Jun 21, 2021

WESA Insider Holdings Chart

Issuer details as of Jun 21, 2021 2:58 ET

Latest Price
2.51
1 Day Change
-5.28%
52 Week High
7.452
52 Week Low
2.25
QMV ($Mils)
31,573,282


Top